SCHEMBL9980486

SCHEMBL9980486

COCC1CCN(c2ccc(S(N)(=O)=O)cc2CNc2ncnc3[nH]nc(-c4ccoc4)c23)CC1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR2 O15552 1/20 0.33
KMT2A Q03164 4/20 0.32
USP2 O75604 4/20 0.32
ALDH1A1 P00352 4/20 0.32
CYP1A2 P05177 4/20 0.32
CYP3A4 P08684 4/20 0.32
CYP2D6 P10635 4/20 0.32
CYP2C19 P33261 4/20 0.32
TSHR P16473 3/20 0.32
CLK4 Q9HAZ1 3/20 0.32
MEN1 O00255 3/20 0.32
HSD17B10 Q99714 3/20 0.32
LMNA P02545 2/20 0.32
MAPK1 P28482 2/20 0.32
HIF1A Q16665 2/20 0.32
WDR5 P61964 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA7 P43166 1/20 0.31
CA13 Q8N1Q1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12065843 0.82 TNNI3K (0.48) KMT2AWDR5
SCHEMBL9980411 0.81 CYP1A2 (0.45) KMT2AUSP2ALDH1A1CYP1A2CYP3A4
SCHEMBL9980382 0.78 USP2 (0.36) KMT2AUSP2ALDH1A1CYP1A2CYP3A4
SCHEMBL9980424 0.76 TNNI3K (0.35) FFAR2CYP2D6LMNACA1CA2
SCHEMBL9980493 0.75 TNNI3K (0.36) FFAR2ALDH1A1CYP2D6CA1CA2
SCHEMBL9980448 0.74 LRRK2 (0.42) ALDH1A1CA1CA2LRRK2
SCHEMBL9980404 0.73 STK4 (0.39) KMT2AALDH1A1TSHRMEN1HSD17B10
SCHEMBL9980436 0.71 TNNI3K (0.37) KMT2AWDR5CA1CA2CA7
SCHEMBL9986489 0.71 TNNI3K (0.52) KMT2AWDR5
SCHEMBL12066469 0.70 TNNI3K (0.53) KMT2AWDR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011149827-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-12-01 WO claimed
WO-2011149827-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-12-01 WO disclosed